Better Health for All

Azenta's core business, providing life sciences solutions, sample management, and multiomics services, enables breakthroughs and therapies for life-threatening conditions like hemophilia, HIV, sickle cell disease, and cancer.

The company has no products with significant negative health impacts. However, in 2024, its subsidiary Barkey issued one voluntary recall of 26 units and received one warning letter. Azenta's products, such as gene therapies, often cost hundreds of thousands or millions of dollars per patient in the U.S. and Europe, though academic trials in India show manufacturing costs for CAR-T cell therapies at around $35,000 per patient. The company aims to bridge the gap in access to gene therapy for low- and middle-income countries and partners with Just-A-Start to reach underrepresented groups in STEM education. Azenta invests in health innovation through collaborations like the FinnGen project for proteomics profiling on up to 20,000 individuals and supporting Lupus research. The Global Gene Therapy Initiative (GGTI), founded in 2020, aims to ensure global access to genetic treatments regardless of geography or financial status. Azenta offers an Employee Assistance Program (EAP) providing up to three mental health sessions and online/in-person counseling, and promotes mental health awareness. The company's information security program aligns with international standards, including GDPR, and includes data encryption and annual employee training. Azenta supports preventative health by promoting mental health awareness and offering a well-being program. The company provides career training, tuition reimbursement, and leadership training for its employees, and engages in STEM education initiatives. Azenta provides multiomics services across clinical research and has a Human Rights Policy covering non-discrimination and privacy. The company's project in the DRC, valued at €100 million, aims to improve vaccine storage and transport, but no specific crisis response actions are detailed.

Fair Money & Economic Opportunity

Azenta, Inc. is a provider of life sciences and automation solutions

, not a financial institution. The company's customers are primarily pharmaceutical and biotechnology companies, research hospitals, academic institutions, and biotech start-ups. As such, Azenta does not offer lending, deposit, or consumer credit products. Therefore, all KPIs related to financial services, such as underserved client share, pricing fairness, exploitative fee exposure, financial inclusion initiatives, data accessibility (for financial data), fair lending compliance, wealth building outcome, profit reinvestment (in community finance), financial literacy initiatives (for customers), debt burden ratio, geographic inclusion (banking deserts), and product simplicity (of financial products), are not applicable to its core business model. The company's reported initiatives focus on employee diversity , internal financial wellness programs , and general corporate governance , which do not align with the specific financial services criteria of this value.

Fair Pay & Worker Respect

For the 2024 fiscal year, Azenta, Inc.'s CEO pay ratio was 121:1, with the CEO's total compensation at $6,763,201 and the median employee pay at $56,095.

In the AZENTA UK LTD 2024-25 Gender Pay Gap Report, women earned 82p for every £1 earned by men in median hourly pay, representing an 18% difference. Women's median bonus pay was 17.6% lower than men's, while their mean bonus pay was 13.2% higher. The report also shows that 83.6% of women received bonus pay compared to 88.0% of men.

Fair Trade & Ethical Sourcing

Azenta, Inc. filed a Conflict Minerals Report for calendar year 2024, detailing its due diligence process for minerals sourced from the Democratic Republic of Congo and nine adjoining countries.

This process is designed in accordance with OECD Due Diligence Guidance. The company identified 346 smelters and refineries in its supply chain, with 49 potentially sourcing from Covered Countries. Of these, 34 smelters have been audited and are compliant with the Reasonable Minerals Assurance Process (RMAP). Risk mitigation processes are in place for the remaining 15 smelters. Azenta has a conflict minerals policy, internal management systems, transparency processes, and a grievance mechanism. The company plans to improve its due diligence in 2025 by including conflict minerals clauses in supplier contracts and encouraging RMAP certification.

Honest & Fair Business

Azenta has a formal whistleblower protection policy with a 24/7 confidential Ethics Hotline, staffed by a third-party provider, available in multiple languages, and an online reporting system.

The policy prohibits retaliation, and complaints are reviewed and investigated with legal resources. The company also has a Global Anti-Corruption Policy, effective February 1, 2022, which prohibits bribery, kickbacks, and facilitation payments, and includes specific guidelines for gifts, meals, entertainment, and travel. This policy covers all directors, officers, employees, agents, representatives, and associated persons, and adheres to regulations like the FCPA and UK Bribery Act. However, there is no evidence of training frequency or effectiveness metrics for this policy. Additionally, approximately 45% of ethical claims are independently verified, with verification becoming more systematic.

Kind to Animals

Azenta Inc. uses animals in pre-clinical studies for medication safety testing, as explicitly stated on its website.

There is no information provided regarding any policy to reduce or prohibit animal testing, or the use of alternative testing methods.

Planet-Friendly Business

Azenta's total Scope 1 and 2 GHG emissions (market-based) were 14,136 metric tons CO2e in FY2024, representing a 6.2% decline from FY2023.

The company has committed to aligning its emissions targets with the Science Based Targets initiative (SBTi) and plans to seek validation by the end of calendar year 2025. It aims to reduce Scope 1 and 2 GHG emissions by 55% by 2033 from a 2022 base year and reach net-zero GHG emissions across the value chain by 2050. Over 60% of the company's electricity usage in 2024 was sourced from renewable electricity. Starting January 2025, all SBS tube rack bases will be manufactured with up to 90% recycled polypropylene. Azenta published its inaugural Task Force on Climate-related Financial Disclosures (TCFD) Index and conducted a qualitative analysis of climate-related physical and transition risks and opportunities. The company partnered with EcoVadis to evaluate and monitor supplier sustainability performance, with 55% of Tier 1 suppliers (by spend) having been assessed.

Respect for Cultures & Communities

Azenta has established 5 formal partnerships with local community groups, including The Posse Foundation, Just-A-Start, United Way, University of Massachusetts Lowell's RAMP program, and The Federation of Bombay Blood Bank in India.

The company reported no cultural appropriation incidents. An Ethics Hotline is available for confidential and anonymous reporting of policy violations, which represents a standard grievance process. FPIC processes are not applicable to Azenta's operations. All Azenta employees are required to participate in annual ethics training, which is a standard diversity training without specific cultural sensitivity components.

Safe & Smart Tech

Azenta has not, to its knowledge, experienced any significant system failure, accident, or material cybersecurity incident to date.

The company holds numerous certifications including ISO 9001:2015, ISO 13485:2016, ISO 27001:2022 (for Suzhou, China), CAP Biorepository Accreditation, EMA GMP Compliance, PMDA Accreditation, NRC, NABP, GDP, GMO, CLIA, GLP, and GCP. All Azenta Life Sciences employees annually review the International Data Protection Policy SOP. The company supports 1028-bit encryption and secures data in transit with Transport Layer Security (TLS). Data is backed up daily, with the last five days of backups stored in the cloud. Samples are destroyed only upon client’s written request by an authorized project contact. User authentication is via active directory domain services (LDAP) in the Enterprise edition, and secondary factor authentication is used for remote access to systems. Operating system level vulnerability monitoring is in place, and advanced persistent threat testing is conducted. The company is subject to and maintains compliance with US federal and state laws (e.g., CCPA, CPRA) and international regulations (e.g., EU GDPR, UK GDPR). The privacy policy states that personal information is retained for ongoing legitimate business needs or to comply with legal requirements, and is deleted or anonymized when no longer needed. The company implements commercially reasonable technical, organizational, physical, and administrative measures to protect information. External service providers are used to assess and test security controls.

Zero Waste & Sustainable Products

Azenta Life Sciences will manufacture SBS tube rack bases for its FluidX sample storage consumables with up to 90% recycled polypropylene, sourced from repurposed material, starting January 2025.

This initiative represents a waste reduction effort, specifically for a component of a product line. The use of recycled material in these tube rack bases demonstrates the application of circular design principles in some product lines.